We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

44 hedge funds and large institutions have $518M invested in Lakefront Biotherapeutics American Depositary Shares in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

41% more capital invested

Capital invested by funds: $368M → $518M (+$150M)

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

16% more funds holding

Funds holding: 38 → 44 (+6)

Holders
44
Holders Change
+6
Holders Change %
+15.79%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
13
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$14.6M
2
EC
EcoR1 Capital
California
+$8.55M
3
CCP
Clough Capital Partners
Massachusetts
+$6.43M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.25M
5
GP
GLG Partners
United Kingdom
+$3M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$23.9M
2
O
OrbiMed
New York
-$14.5M
3
DM
Deerfield Management
New York
-$13.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$11.6M
5
ZDA
Zweig-DiMenna Associates
New York
-$7M
Name Holding Trade Value Shares
Change 		Change in
Stake
EEG
26
E.E. Geduld
$692K +$562K +11,000 New
LCM
27
Landscape Capital Management
New Jersey
$509K +$107K +2,101 +35%
AL
28
Airain Ltd
Guernsey
$474K +$385K +7,541 New
UBS Group
29
UBS Group
Switzerland
$280K +$53.5K +1,046 +31%
CSS
30
Cubist Systematic Strategies
Connecticut
$248K +$202K +3,946 New
NA
31
Navellier & Associates
Nevada
$214K -$428K -8,380 -71%
CI
32
Cavalier Investments
Georgia
$214K +$174K +3,400 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$210K +$171K +3,353 New
CM
34
Castleark Management
Illinois
$189K +$153K +3,000 New
Creative Planning
35
Creative Planning
Kansas
$88K +$5.11K +100 +8%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$41K -$43K -841 -56%
BlackRock
37
BlackRock
New York
$31K +$25.6K +500 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$26K – – –
Bank of America
39
Bank of America
North Carolina
$16K -$1.94M -37,989 -99%
Walleye Trading
40
Walleye Trading
New York
$13K -$15.3K -300 -60%
EWM
41
Edge Wealth Management
New York
$13K – – –
Citigroup
42
Citigroup
New York
$3K +$1.53K +30 +158%
US Bancorp
43
US Bancorp
Minnesota
$3K +$2.35K +46 New
GGHC
44
Gilder Gagnon Howe & Co
New York
– -$23.9M -585,870 Closed
ZDA
45
Zweig-DiMenna Associates
New York
– -$7M -171,840 Closed
RIM
46
RS Investment Management
California
– -$3.96M -97,182 Closed
GAMA
47
Graticule Asia Macro Advisors
New York
– -$2.04M -50,000 Closed
OMC
48
Old Mission Capital
Illinois
– -$1.73M -42,473 Closed
Jane Street
49
Jane Street
New York
– -$1.06M -25,984 Closed
BIM
50
Bogle Investment Management
Massachusetts
– -$1.02M -25,192 Closed
1
2
3

LKFT Hedge Fund Activity: Q4 2015 in Review

44 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q4 2015, worth a combined $518M — up 41% from $368M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LKFT positions and 10 closed out — a net gain of 6 holders — while 13 added to existing stakes and 10 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $14.6M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $23.9M sold.

  • 44 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q4 2015, up from 38 in Q3 2015.
  • Funds reported $518M of Lakefront Biotherapeutics American Depositary Shares stock for Q4 2015, up 41% quarter-over-quarter.
  • 16 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q4 2015 and 10 closed out, a net change of +6 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q4 2015 was Wellington Management Group, an estimated $14.6M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q4 2015 was Gilder Gagnon Howe & Co, an estimated $23.9M sold.

Based on aggregated 13F filings for Q4 2015.